Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion.

MLA

Castillo, Martín I., et al. “Incidence and Prognostic Impact of U2AF1 Mutations and Other Gene Alterations in Myelodysplastic Neoplasms with Isolated 20q Deletion.” Cancer Medicine, vol. 12, no. 16, Aug. 2023, pp. 16788–92. EBSCOhost, https://doi.org/10.1002/cam4.6300.

APA

Castillo, M. I., Ribate, V. E., Muñoz, C. M., Santillana, S. G., Taboada, S. E., Casterá, M. E., Abinzano, C. M. J., Barranco, I. A., Nieto, C. R., Pampliega, V. M., Blanco, M. L., de Andrés, Á. S., de Oteyza, P. J., del Castillo, B. T., Font, G. I., Cayuela, J. A., Díez, C. M., Sánchez, A. R., Vercet, S. C., & Díaz, T. M. (2023). Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion. Cancer Medicine, 12(16), 16788–16792. https://doi.org/10.1002/cam4.6300

Chicago

Castillo, Martín I., Villamón E. Ribate, Calabuig M. Muñoz, Sanz G. Santillana, Such E. Taboada, Mora E. Casterá, Calasanz M. J. Abinzano, et al. 2023. “Incidence and Prognostic Impact of U2AF1 Mutations and Other Gene Alterations in Myelodysplastic Neoplasms with Isolated 20q Deletion.” Cancer Medicine 12 (16): 16788–92. doi:10.1002/cam4.6300.